Symptoms and levels of ICD-11 Prolonged Grief Disorder in a representative community sample of UK adults.
Epidemiology
Prevalence
Prolonged Grief Disorder
Risk factors
Journal
Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
23
09
2022
accepted:
30
03
2023
medline:
28
8
2023
pubmed:
12
4
2023
entrez:
11
4
2023
Statut:
ppublish
Résumé
Prolonged Grief Disorder (PGD) is a new disorder included in ICD-11 (WHO, 2018). There is a growing body of literature surrounding the prevalence and correlates of ICD-11 PGD symptoms as assessed using various measures. This study was the first to assess levels of ICD-11 PGD symptoms as measured by the International Prolonged Grief Disorder Scale (IPGDS), a self-report scale directly aligned with the ICD-11 definition of PGD, among the United Kingdom adult general population, and identify correlates. Participants included 2025 adults who participated in Wave 5 of the COVID-19 Psychological Research Consortium Study (C19PRC-UK). Prevalence rates of PGD were estimated based on two commonly used algorithms defined as 'strict' and 'moderate'. Sociodemographic, loss-related, and mental health correlates (i.e., anxiety, depression, mental health treatment seeking, loneliness) of strict and moderate PGD were then examined using multinomial logistic regressions. It was found that 2.4% (n = 43) of participants met probable caseness for PGD using the strict criteria while 7.9% (n = 140) met probable caseness for PGD using the moderate criteria. Multinomial logistic regression analysis results showed, as predicted, that income, time since bereavement, death of a child, religiosity, and depression were associated with both moderate and strict PGD. Correlates of moderate PGD included country of residence, urbanicity, younger age of bereaved, and loneliness. This study highlights that some symptoms of PGD are commonly reported in the general population, although relatively few meet the criteria for clinical significance. The routine assessment for PGD following a bereavement is discussed and the development of appropriate interventions are recommended.
Sections du résumé
BACKGROUND
BACKGROUND
Prolonged Grief Disorder (PGD) is a new disorder included in ICD-11 (WHO, 2018). There is a growing body of literature surrounding the prevalence and correlates of ICD-11 PGD symptoms as assessed using various measures. This study was the first to assess levels of ICD-11 PGD symptoms as measured by the International Prolonged Grief Disorder Scale (IPGDS), a self-report scale directly aligned with the ICD-11 definition of PGD, among the United Kingdom adult general population, and identify correlates.
METHOD
METHODS
Participants included 2025 adults who participated in Wave 5 of the COVID-19 Psychological Research Consortium Study (C19PRC-UK). Prevalence rates of PGD were estimated based on two commonly used algorithms defined as 'strict' and 'moderate'. Sociodemographic, loss-related, and mental health correlates (i.e., anxiety, depression, mental health treatment seeking, loneliness) of strict and moderate PGD were then examined using multinomial logistic regressions.
RESULTS
RESULTS
It was found that 2.4% (n = 43) of participants met probable caseness for PGD using the strict criteria while 7.9% (n = 140) met probable caseness for PGD using the moderate criteria. Multinomial logistic regression analysis results showed, as predicted, that income, time since bereavement, death of a child, religiosity, and depression were associated with both moderate and strict PGD. Correlates of moderate PGD included country of residence, urbanicity, younger age of bereaved, and loneliness.
CONCLUSIONS
CONCLUSIONS
This study highlights that some symptoms of PGD are commonly reported in the general population, although relatively few meet the criteria for clinical significance. The routine assessment for PGD following a bereavement is discussed and the development of appropriate interventions are recommended.
Identifiants
pubmed: 37039844
doi: 10.1007/s00127-023-02469-1
pii: 10.1007/s00127-023-02469-1
pmc: PMC10098228
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1535-1547Informations de copyright
© 2023. The Author(s).
Références
Psychiatry Res. 2014 Oct 30;219(2):347-52
pubmed: 24924526
BMJ. 2002 Jun 29;324(7353):1551
pubmed: 12089091
Compr Psychiatry. 2022 Jan;112:152281
pubmed: 34700189
J Affect Disord. 2020 Dec 1;277:568-576
pubmed: 32896722
Clin Psychol Psychother. 2022 Nov;29(6):1950-1962
pubmed: 35751156
Curr Opin Psychol. 2022 Feb;43:48-64
pubmed: 34293651
Eur J Psychotraumatol. 2015 May 19;6:27303
pubmed: 25994020
J Psychiatr Res. 2020 Oct;129:168-175
pubmed: 32739617
Br J Psychiatry. 2006 Jan;188:51-7
pubmed: 16388070
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Eur J Psychotraumatol. 2019 Mar 27;10(1):1583524
pubmed: 30949303
Res Aging. 2004;26(6):655-672
pubmed: 18504506
Clin Psychol Eur. 2021 Mar 10;3(1):e4159
pubmed: 36397782
Int J Methods Psychiatr Res. 2022 Dec;31(4):e1928
pubmed: 35759532
J Affect Disord. 2021 Jan 15;279:89-97
pubmed: 33039779
World Psychiatry. 2021 Feb;20(1):96-106
pubmed: 33432758
Psychiatry Res. 2020 Jan 13;285:112786
pubmed: 32000105
Soc Psychiatry Psychiatr Epidemiol. 2014 Mar;49(3):435-46
pubmed: 23959590
J Pers Soc Psychol. 2002 Nov;83(5):1150-64
pubmed: 12416919
BMC Public Health. 2020 May 27;20(1):778
pubmed: 32456626
Trials. 2018 Apr 20;19(1):241
pubmed: 29678193
Death Stud. 2022;46(6):1287-1296
pubmed: 35167429
CMAJ. 2012 Feb 21;184(3):E191-6
pubmed: 22184363
Int J Popul Data Sci. 2022 Feb 07;5(4):1704
pubmed: 35310464
Depress Anxiety. 2015 Jul;32(7):485-92
pubmed: 26061724
World Psychiatry. 2022 Jun;21(2):189-213
pubmed: 35524599
JAMA Psychiatry. 2014 Dec 1;71(12):1332-9
pubmed: 25338187
Psychol Med. 2008 Oct;38(10):1485-93
pubmed: 18184442
Eur J Psychotraumatol. 2022 May 09;13(1):2062998
pubmed: 35572390
Compr Psychiatry. 2017 Jan;72:6-12
pubmed: 27683967
J Affect Disord. 2017 Apr 01;212:138-149
pubmed: 28167398
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Curr Psychiatry Rep. 2012 Jun;14(3):169-75
pubmed: 22538558
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
J Affect Disord. 2010 Sep;125(1-3):374-8
pubmed: 20189657
Depress Anxiety. 2019 Sep;36(9):887-894
pubmed: 31268218
Acta Psychiatr Scand. 2018 Dec;138(6):536-546
pubmed: 30178492
Arch Gen Psychiatry. 2009 Jul;66(7):785-95
pubmed: 19581570
Psychiatry Res. 2020 Jun;288:113031
pubmed: 32360895
Br J Psychiatry. 2021 Sep;219(3):473-476
pubmed: 31718725
Global Health. 2021 Feb 11;17(1):19
pubmed: 33573673
Acta Psychiatr Scand. 2020 Mar;141(3):265-274
pubmed: 31721147
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941